Prelude Therapeutics
PRLD
#9472
Rank
A$94.69 M
Marketcap
$1.72
Share price
-7.02%
Change (1 day)
-69.56%
Change (1 year)

Revenue for Prelude Therapeutics (PRLD)

Revenue in 2024 (TTM): A$4.33 Million

According to Prelude Therapeutics's latest financial reports the company's current revenue (TTM ) is A$4.86 Million. In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prelude Therapeutics from 2020 to 2024

202120222023$1M$2M$3M$4M$5M0companiesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) A$4.33 M
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA